Dabigatran malabsorption in amiodarone-induced thyrotoxicosis: a clinical report

Intern Emerg Med. 2016 Sep;11(6):889-90. doi: 10.1007/s11739-016-1434-6. Epub 2016 Mar 17.

Authors

Francesco Sbrana¹, Dario Genovesi², Giosuè Angelo Catapano², Luca Panchetti², Antonio Bottoni², Giorgio Iervasi³

Affiliations

¹ Fondazione Toscana Gabriele Monasterio, Via Moruzzi 1, 56124, Pisa, Italy. francesco.sbrana@ftgm.it.
² Fondazione Toscana Gabriele Monasterio, Via Moruzzi 1, 56124, Pisa, Italy.
³ Institute of Clinical Physiology, Italian National Research Council, Via Moruzzi 1, 56124, Pisa, Italy.

PMID: 26984205
DOI: 10.1007/s11739-016-1434-6

No abstract available

Publication types

Letter

MeSH terms

Aged
Amiodarone / adverse effects
Amiodarone / therapeutic use
Anti-Arrhythmia Agents / adverse effects
Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation / complications
Atrial Fibrillation / drug therapy
Dabigatran / adverse effects*
Dabigatran / therapeutic use
Echocardiography
Humans
International Normalized Ratio
Malabsorption Syndromes / complications
Malabsorption Syndromes / diagnosis*
Male
Prothrombin Time
Thyrotoxicosis / complications
Thyrotoxicosis / etiology*

Substances

Anti-Arrhythmia Agents
Dabigatran
Amiodarone